XML 64 R13.htm IDEA: XBRL DOCUMENT v2.4.0.6
Income Taxes
12 Months Ended
Dec. 31, 2012
Income Taxes [Abstract]  
Income Taxes
Note 5. Income Taxes
 
Total income taxes were allocated as follows:

   
2012
  
2011
 
Total tax expense on income
 $646  $25 
          
Tax expense on components of shareholders' equity:
        
Net unrealized gains on investment securities
  3,688   6,681 
Fair value adjustment to derivative financial instrument
  257   237 
Total tax expense on shareholders' equity
  3,945   6,918 
Total tax expense
 $4,591  $6,943 

A reconciliation of the differences between income taxes computed at the federal statutory income tax rate and the income tax expense is as follows:

   
2012
  
2011
 
Federal income tax provision at statutory rate of 35%
 $1,779  $1,160 
Dividends received deduction
  (175 )  (173 )
Small life insurance company deduction
  (485 )  (617 )
Other
  46   18 
Change in asset valuation allowance due to change in judgment relating to realizability of deferred tax assets
  (440 )  (412 )
Adjustment for prior years' estimates to actual
  (79 )  49 
Income tax expense
 $646  $25 

The primary differences between the effective tax rate and the federal statutory income tax rate resulted from the dividends-received deduction ("DRD"), the small life insurance company deduction ("SLD") and the change in deferred tax asset valuation allowance. The current estimated DRD is adjusted as underlying factors change and can vary from the estimates based on, but not limited to, actual distributions from these investments as well as the amount of the Company's taxable income. The SLD varies in amount and is determined at a rate of 60 percent of the tentative life insurance company taxable income ("LICTI"). The SLD for any taxable year is reduced (but not below zero) by 15 percent of the tentative LICTI for such taxable year as it exceeds $3,000 and is ultimately phased out at $15,000. The change in deferred tax asset valuation allowance was primarily due to the unanticipated utilization of certain capital loss carryforward benefits that had been previously reserved.
 
Deferred tax liabilities and assets at December 31, 2012 and 2011 were comprised of the following:

   
2012
  
2011
 
Deferred tax liabilities:
      
Deferred acquisition costs
 $(4,197) $(4,255)
Deferred and uncollected premiums
  (743 )  (736 )
Net unrealized investment gains
  (10,588 )  (6,900 )
Other
  (8 )  (18 )
Total deferred tax liabilities
  (15,536 )  (11,909 )
Deferred tax assets:
        
Net operating loss carryforwards
  1,575   1,429 
Insurance reserves
  4,516   4,341 
Capital loss carryforwards
  5,236   5,675 
Impaired assets
  1,406   1,443 
Alternative minimum tax credit
  306   510 
Bad debts and other
  601   903 
Total deferred tax assets
  13,640   14,301 
Asset valuation allowance
  (5,268 )  (5,708 )
Net deferred tax liability
 $(7,164) $(3,316)

The components of income tax expense were:

   
2012
  
2011
 
Current - Federal
 $743  $399 
Deferred - Federal
  343   38 
Change in deferred tax asset valuation allowance
  (440 )  (412 )
Total
 $646  $25 

At December 31, 2012, the Company had regular federal net operating loss carryforwards ("NOLs") of approximately $4,500 expiring generally between 2025 and 2032. Currently, the Company believes that deferred income tax benefits relating to the NOLs will be realized. However, expected realization of the NOLs is assessed periodically based on the Company's then current and anticipated results of operations, and amounts could increase or decrease if estimates of future taxable income change.

As of December 31, 2012 and 2011, a valuation allowance of $5,268 and $5,708, respectively, was established against deferred income tax benefits relating primarily to capital loss carryforwards that may not be realized. The Company does not currently anticipate having sufficient future capital gains to offset certain of these capital losses during the applicable carryforward period. However, the Company continues to periodically assess the potential realization of these and all other deferred tax benefits. During 2012, the Company's valuation allowance decreased by $440. The decrease was primarily due to the unanticipated utilization of certain capital loss carryforward benefits that had been previously reduced to zero through an existing valuation allowance reserve.

The Company has formal tax-sharing agreements, and files a consolidated income tax return, with its subsidiaries.